p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice (Q33624820)

28 July 2017

p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice (English)

1 reference

28 July 2017

1 reference

5

Atsuyasu Sato

1 reference

28 July 2017

Satoshi Marumo

1

1 reference

28 July 2017

Yuma Hoshino

2

1 reference

28 July 2017

Hirofumi Kiyokawa

3

1 reference

28 July 2017

Naoya Tanabe

4

1 reference

28 July 2017

Emiko Ogawa

6

1 reference

28 July 2017

Shigeo Muro

7

1 reference

28 July 2017

Toyohiro Hirai

8

1 reference

28 July 2017

Michiaki Mishima

9

1 reference

28 July 2017

7 May 2014

1 reference

28 July 2017

BMC Pulmonary Medicine

1 reference

28 July 2017

14

1 reference

28 July 2017

79

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2466-14-79

28 July 2017

0 references

cites work

Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

p38 mitogen-activated protein kinase pathways in asthma and COPD.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

The cytokine network in chronic obstructive pulmonary disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Identifying targets for COPD treatment through gene expression analyses.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Animal models of chronic obstructive pulmonary disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Emerging role of MAP kinase pathways as therapeutic targets in COPD.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Morphological mechanism of the development of pulmonary emphysema in klotho mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Chronic obstructive pulmonary disease: current burden and future projections.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Fibulin-5/DANCE is essential for elastogenesis in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Mammalian MAP kinase signalling cascades

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

A novel model of senile lung: senescence-accelerated mouse (SAM).

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

P38 inhibition in COPD; cautious optimism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

The development of emphysema in cigarette smoke-exposed mice is strain dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Overview of the World Health Report 2000 Health systems: improving performance.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

A murine model of smoke inhalation.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4024315

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Increased activation of p38 MAPK in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-79

Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema

21 January 2018

1 reference

12 December 2020

Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages

1 reference

12 December 2020

Up-regulation of ERK (MAP kinase) and MEK (MAP kinase kinase) transcription after rat facial nerve transection

1 reference

12 December 2020

Effect of smoking cessation on airway inflammation in chronic bronchitis

1 reference

12 December 2020

Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function

1 reference

12 December 2020

Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models

1 reference

12 December 2020

Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis

1 reference

12 December 2020

Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice

1 reference

12 December 2020

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2466-14-79

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference